Between 30 and 40 percent of human breast cancers express a defective (mutant) form of p53, a protein that helps cancer cells proliferate and grow. Researchers found that combining a cancer therapy, which activates p53 and is currently under a clinical trial, with a second drug therapy that helps suppress tumor blood vessels found in cancer cells, can significantly reduce breast cancer tumors while causing cancer cell death.
from Top Health News – ScienceDaily http://bit.ly/2GueoO8
from Tumblr http://bit.ly/2DWQg1x
No comments:
Post a Comment